Oculis Holding AG (OCS)

NASDAQ: OCS · Real-Time Price · USD

17.70

+0.06 (0.34%)

Aug 1, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Innovative Drug	778.95K	Log In
Innovative Drug Growth	-20.72%	Log In